Zhaxybay Zhumadilov, M.D., Ph.D. is the current Director-General of the “National Laboratory Astana”, at Nazarbayev University, in Astana, Kazakhstan.  He is the author of 550 peer-reviewed publications, and more than 29 inventions and patents.

Dr. Zhumadilov has contributed to numerous scientific and social advancements. He developed some new methods to prevent septic complications from abdominal surgery. He invented, and implemented, erythrocyte pharmacocytes for treatment of patients with acute cholangites, biliary abscesses, and acute complicated cholecystitis into clinical practice for the first time, as well as a new method for treatment of severe soft tissue infections.  He implemented fine-needle aspiration biopsy, in the Semipalatinsk region of Kazakhstan, to detect thyroid nodular diseases and thyroid cancer in areas adjacent to the Semipalatinsk Nuclear Test Site, and he further invented, and implemented, some new treatment methods for thyroid nodular diseases. He conducted a research project to study the relationships between fallout exposure and iodine deficiency in areas adjacent to the Semipalatinsk Nuclear Test Site. He implemented some improvements to the screening and treatment algorithms for thyroid nodular diseases in the Semipalatinsk Region of Kazakhstan. He organized, and conducted, thyroid screening and medical rehabilitation of the exposed population, participated in establishing the National Medical Holding in Kazakhstan and Life Sciences Center of Nazarbayev University, Astana, and, finally, invented and implemented the “Consortium of Probiotics” (Eurasian Patent Organization #14/017593-13, 30.01.2013).